Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23403953)

1.

Susceptibility of hepatoma-derived cells to histone deacetylase inhibitors is associated with ID2 expression.

Tsunedomi R, Iizuka N, Harada S, Oka M.

Int J Oncol. 2013 Apr;42(4):1159-66. doi: 10.3892/ijo.2013.1811. Epub 2013 Feb 6.

2.

Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.

Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C, Meyn RE.

Clin Cancer Res. 2005 Jul 1;11(13):4912-22.

3.

Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.

Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.

Eur J Haematol. 2006 Jan;76(1):42-50.

PMID:
16343270
4.

HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.

Pathil A, Armeanu S, Venturelli S, Mascagni P, Weiss TS, Gregor M, Lauer UM, Bitzer M.

Hepatology. 2006 Mar;43(3):425-34.

PMID:
16583461
5.

Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.

Condorelli F, Gnemmi I, Vallario A, Genazzani AA, Canonico PL.

Br J Pharmacol. 2008 Feb;153(4):657-68. Epub 2007 Dec 3.

6.

Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.

Shin H, Lee YS, Lee YC.

Oncol Rep. 2012 Apr;27(4):1111-5. doi: 10.3892/or.2011.1585. Epub 2011 Dec 8.

7.

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.

Gastroenterology. 2012 Sep;143(3):811-20.e1-15. doi: 10.1053/j.gastro.2012.05.033. Epub 2012 May 26.

PMID:
22641068
8.

Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells.

Dos Santos Ferreira AC, Fernandes RA, Kwee JK, Klumb CE.

J Cancer Res Clin Oncol. 2012 Feb;138(2):317-25. doi: 10.1007/s00432-011-1093-y. Epub 2011 Dec 1.

PMID:
22131152
9.

Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.

Suenaga M, Soda H, Oka M, Yamaguchi A, Nakatomi K, Shiozawa K, Kawabata S, Kasai T, Yamada Y, Kamihira S, Tei C, Kohno S.

Int J Cancer. 2002 Feb 10;97(5):621-5.

PMID:
11807787
11.

Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.

Chiba T, Yokosuka O, Fukai K, Kojima H, Tada M, Arai M, Imazeki F, Saisho H.

Oncology. 2004;66(6):481-91.

PMID:
15452378
12.
13.

Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.

Zhang CZ, Chen GG, Merchant JL, Lai PB.

Cell Cycle. 2012 Jan 15;11(2):322-34. doi: 10.4161/cc.11.2.18758. Epub 2012 Jan 15.

14.

Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.

Mühlethaler-Mottet A, Meier R, Flahaut M, Bourloud KB, Nardou K, Joseph JM, Gross N.

Mol Cancer. 2008 Jun 12;7:55. doi: 10.1186/1476-4598-7-55.

15.

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.

Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O.

Blood. 2003 May 1;101(9):3451-9. Epub 2003 Jan 2.

17.

[Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].

Shen WJ, Dai DQ, Teng Y, Liu J.

Zhonghua Yi Xue Za Zhi. 2008 Apr 29;88(17):1192-6. Chinese.

PMID:
18844115
19.

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

Armeanu S, Pathil A, Venturelli S, Mascagni P, Weiss TS, Göttlicher M, Gregor M, Lauer UM, Bitzer M.

J Hepatol. 2005 Feb;42(2):210-7.

PMID:
15664246
20.

Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.

Zhu K, Qu D, Sakamoto T, Fukasawa I, Hayashi M, Inaba N.

Arch Gynecol Obstet. 2008 Jan;277(1):15-9. Epub 2007 Aug 7.

PMID:
17680259
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk